Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Inflammatory Breast Cancer

fluorodeoxyglucose f18 has been researched along with Inflammatory Breast Cancer in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (81.82)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Le-Petross, HT; Patel, MM1
Bellon, J; Cheng, SC; DiPiro, PJ; Hu, J; Jacene, HA; Nakhlis, F; Overmoyer, B; Rosenbluth, JM; Schlosnagle, E; Warren, L; Yeh, E1
Bellon, JR; Cheng, SC; DiPiro, PJ; Franchetti, Y; Hu, J; Jacene, HA; Nakhlis, F; Overmoyer, B; Rosenbluth, J; Schlosnagle, E; Shah, H; Warren, L; Yeh, E; Youn, T1
Alberini, JL; Bellet, D; Champion, L; Cherel, P; Edeline, V; Giraudet, AL; Lerebours, F; Wartski, M1
Adrada, BE; Buchholz, TA; Carkaci, S; Mawlawi, OR; Ozkan, E; Rohren, EM; Sherman, CT; Ueno, NT; Wei, W; Yang, WT1
Lichert, F1
Álvarez-Pérez, RM; Borrego-Dorado, I; Caballero-Gullón, L; Martínez-Esteve, A; Sancho-Márquez, MP1
Al-Faham, Z; Al-Katib, S; Bhavnagri, S; Jaiyesimi, I1
Costelloe, CM; Hayashi, N; Hortobagyi, GN; Liu, J; Madewell, JE; Niikura, N; Palla, SL; Theriault, RL; Tokuda, Y; Ueno, NT; Yu, TK1
Alvarez, RH; Buchholz, TA; Lucci, A; Niikura, N; Rohren, E; Ueno, NT; Valero, V; Walker, GV; Woodward, WA; Yang, W1
Cuvier, C; Delord, M; Espié, M; Giacchetti, S; Groheux, D; Hennequin, C; Hindié, E; Merlet, P; Toubert, ME; Vercellino, L1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and Inflammatory Breast Cancer

ArticleYear
Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review.
    Chinese clinical oncology, 2021, Volume: 10, Issue:6

    Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2021

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Inflammatory Breast Cancer

ArticleYear
18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:1

    Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed

2013

Other Studies

9 other study(ies) available for fluorodeoxyglucose f18 and Inflammatory Breast Cancer

ArticleYear
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
    Breast cancer research and treatment, 2020, Volume: 181, Issue:2

    Topics: Adult; Aged; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammatory Breast Neoplasms; Middle Aged; Neoplasm Staging; Patient Care Planning; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tomography, X-Ray Computed

2020
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
    Clinical breast cancer, 2019, Volume: 19, Issue:2

    Topics: Adult; Aged; Axilla; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Lymph Node Excision; Mastectomy; Middle Aged; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk; Survival Analysis; Treatment Outcome

2019
¹⁸F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:8

    Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed

2013
(18)F-FDG PET/CT predicts survival in patients with inflammatory breast cancer undergoing neoadjuvant chemotherapy.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed

2013
[Mammary carcinoma -¹⁸F-FDG-PET-CT-staging vs. conventional staging].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2013, Volume: 185, Issue:7

    Topics: Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed

2013
Breast metastasis from melanoma mimicking inflammatory breast cancer.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:2

    Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Melanoma; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2016
Evaluation of a Case of Inflammatory Breast Cancer with 18F-FDG PET/CT.
    Journal of nuclear medicine technology, 2015, Volume: 43, Issue:4

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed

2015
Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.
    The oncologist, 2011, Volume: 16, Issue:6

    Topics: Adult; Breast Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Tomography, X-Ray Computed

2011
Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.
    International journal of radiation oncology, biology, physics, 2012, Aug-01, Volume: 83, Issue:5

    Topics: Adult; Aged; Axilla; Breast; Female; Fluorodeoxyglucose F18; Humans; Inflammatory Breast Neoplasms; Lymph Nodes; Lymphatic Irradiation; Mastectomy; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Postoperative Care; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Residual Volume; Retrospective Studies; Tomography, X-Ray Computed

2012